YD Bio Limited (YDESW)
NGM · Healthcare · Services-Medical Laboratories
$0.65
-0.02%
Closing price as of 2026-10-29 · Source: TEK2day Finance
Key Metrics
Exchange
NGM
Currency
USD
About YD Bio Limited
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 350K | 510K | 597K |
| Gross Profit | 153K | 155K | 167K |
| Operating Income | (7K) | (1.5M) | (5.3M) |
| Net Income | 14K | (1.4M) | (8.3M) |